FOCIS EUROPEAN ADVANCED COURSE/2027 EDITION19–23 October 2027

FOCIS EUROPEAN ADVANCED COURSE · 2027

Welcome

focis2027normandy, Focis 2027, FOCIS2027 - Normandy

WELCOME TO FOCIS

The European Advanced Course and Conference on Immunology and Immunopathology is an intensive educational meeting connecting fundamental immunology with human disease and clinical practice.

Course description

By means of plenary lectures and scientific seminars, this five-day course provides high-quality, up-to-date comprehensive coverage of major topics in immunology, including the mechanisms involved in innate and adaptive immunity at molecular and cellular levels.

The molecular and genetic basis of immunologically mediated diseases, cancer immunology, as well as recent advances in interventional and clinical immunology are also addressed.

In addition, a participative workshop allows attendees to acquire essential skills on building a clinical trial and drafting a protocol. Junior researchers selected based on the quality of their submitted abstracts have the opportunity to share their own work. Participants can interact through questions and discussions with distinguished scientists in clinical immunology.

Target audience

The course is intended for:

  • Clinical fellows in disciplines related to immunology.
  • PhD and postdoctoral fellows conducting basic research with an emphasis on human disease.
  • Scientists and research and development personnel from biotechnology and pharmaceutical companies involved in developing new therapies for immunological diseases.
  • Academic or community physicians wishing to enhance their understanding of immunology.

Program expectations and learning outcomes

At the conclusion of the course, attendees are expected to be able to master the basis of immunological and immunopathological mechanisms, discuss recent advances and emerging themes in immunology, become familiar with current and upcoming strategies for therapeutic immune intervention, and know the main types of clinical trials in immunology, including the translation of preclinical work into a clinical trial protocol.